Effect of different UCOE-promoter combinations in creation of engineered cell lines for the production of Factor VIII

BackgroundThe most common approach used in generating cell lines for the production of therapetic proteins relies on gene amplification induced by a drug resistance gene e. g., DHFR and glutamine synthetase. Practically, this results in screening large number of clones for the one that expresses high levels of the biologic in a stable manner. The inefficiency of mammalian vector systems to express proteins in a stable manner typically involves silencing of the exogenous gene resulting from modifications such as methylation of CpG DNA sequences, histone deacetylation and chromatin condensation. The use of un-methylated CpG island fragments from housekeeping genes referred to as UCOE (ubiquitous chromatin opening elements) in plasmid vectors is now well established for increased stability of transgene expression. However, few UCOE-promoter combinations have been studied to date and in this report we have tested 14 different combinations.FindingsIn this report we describe studies with two different UCOEs (the 1.5 Kb human RNP fragment and the 3.2 Kb mouse RPS3 fragment) in combination with various promoters to express a large protein (B domain deleted factor VIII; BDD-FVIII) in a production cell line, BHK21. We show here that there are differences in expression of BDD-FVIII by the different UCOE-promoter combinations in both attached and serum free suspension adapted cells. In all cases, the 1.5 Kb human RNP UCOE performed better in expressing BDD-FVIII than their corresponding 3.2 Kb mouse RPS3 UCOE. Surprisingly, in certain scenarios described here, expression from a number of promoters was equivalent or higher than the commonly used and industry standard human CMV promoter.ConclusionThis study indicates that certain UCOE-promoter combinations are better than others in expressing the BDD-FVIII protein in a stable manner in BHK21 cells. An empirical study such as this is required to determine the best combination of UCOE-promoter in a vector for a particular production cell line.

[1]  J. Beckmann,et al.  Genome-wide prediction of matrix attachment regions that increase gene expression in mammalian cells , 2007, Nature Methods.

[2]  A. Dickson,et al.  Advances in animal cell recombinant protein production: GS-NS0 expression system , 2000, Cytotechnology.

[3]  A. E. Sippel,et al.  A nuclear DNA attachment element mediates elevated and position-independent gene activity , 1989, Nature.

[4]  W. Ostertag,et al.  The chicken lysozyme 5' matrix attachment region increases transcription from a heterologous promoter in heterologous cells and dampens position effects on the expression of transfected genes. , 1990, Molecular and cellular biology.

[5]  M. Antoniou,et al.  Correlation of DNA Methylation with Histone Modifications Across the HNRPA2B1-CBX3 Ubiquitously-Acting Chromatin Open Element (UCOE) , 2007, Epigenetics.

[6]  A. Razin,et al.  CpG methylation, chromatin structure and gene silencing—a three‐way connection , 1998, The EMBO journal.

[7]  A. Schambach,et al.  Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells , 2007, Blood.

[8]  François Fuks,et al.  DNA methylation and histone modifications: teaming up to silence genes. , 2005, Current opinion in genetics & development.

[9]  A. Wilson.  Disease of Potatoes , 1883, Nature.

[10]  A. Thrasher,et al.  A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  M. Griffiths,et al.  CpG-island fragments from the HNRPA2B1/CBX3 genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhancer in mammalian cells , 2005, BMC biotechnology.

[12]  R. Kaufman.  Vectors used for expression in mammalian cells. , 1990, Methods in enzymology.

[13]  J. Bode,et al.  Scaffold-attached regions from the human interferon beta domain can be used to enhance the stable expression of genes under the control of various promoters. , 1991, Biochemistry.

[14]  B. Fox,et al.  The use of UCOE vectors in combination with a preadapted serum free, suspension cell line allows for rapid production of large quantities of protein , 2004, Cytotechnology.

[15]  Jolyon Holdstock,et al.  Transgenes encompassing dual-promoter CpG islands from the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing. , 2003, Genomics.

[16]  F. Wurm.  Production of recombinant protein therapeutics in cultivated mammalian cells , 2004, Nature Biotechnology.

[17]  A. Bird,et al.  Methylation-Induced Repression— Belts, Braces, and Chromatin , 1999, Cell.